Among these genes, MTOR (Burchert et al. 2005), STAT3, MCL1 (Bewry et al. 2008), LAMC1 (Zhang et al. 2022), and KRAS (Agarwal et al. 2007) have been reported to play roles in imatinib resistance in chronic myeloid leukemia in parallel with our findings. Here, MTOR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.